In addition, pterostilbene is known to reduce expression of Peroxisome Proliferator Activated Receptors γ (PPARγ) involved in the starting of insulin resistance and dyslipidaemia [51, 52]. The gene discussed is PPARG; the disease is inherited lipid metabolism disorder.